Familial risks of five types of osteoarthritis in first-, second- and third-degree relatives - A nationwide Swedish family study

瑞典一项全国性家族研究:一级、二级和三级亲属罹患五种骨关节炎的家族风险

阅读:1

Abstract

OBJECTIVE: Osteoarthritis (OA) is a common degenerative disease with a genetic contribution. However, no large nationwide family study concerning the heredity of OA has been published. This first nationwide study aimed to determine the familial risks of the main types of OA in twins, full-siblings, half-siblings, and cousins in Sweden. DESIGN: The Swedish Multigeneration register was linked to the National Patient Register (NPR) to investigate the heredity of OA (poly-, hip-, knee-, first carpometacarpal joint-, and other-OA) between 1997 and 2018. Offspring born by Swedish parents were included. The adjusted familial hazard ratios (HRs) with 95 ​% confidence interval (CI) were determined for OA among twins, full-siblings, half-siblings, and cousins. Adjustments were made for birth year, sex, educational level, and comorbidities (chronic obstructive pulmonary disease, alcoholism, and obesity). RESULTS: A total of 6 547 966 individuals (48.77 ​% women) were included with mean age 41.44 years (range 0-86.96 years) at end of follow-up. Familial HRs were increased for all five types of OA (even in cousins) and correlated to degree of genetic resemblance between relatives. For instance, adjusted HRs among full-siblings were for poly-OA 2.29 (95 ​% CI 2.09-2.51), hip-OA 2.04 (95 ​% CI 1.98-2.07), knee-OA 1.75 (95 ​% CI 1.73-1.77), thumb-OA 2.60 (95 ​% CI 2.45-2.76), and other-OA 1.52 (95 ​% CI 1.48-1.56). CONCLUSIONS: Heredity is an important predictor of future risk of OA for all five types of OA in the Swedish population. Strongest heredity was observed for first carpometacarpal joint -OA followed by poly-OA and hip-OA. Weakest heredity was observed for knee-OA and other-OA.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。